Back to NRIX

Kynam Capital Management, LP → NRIX

Kynam Capital Management, LP NRIX Position History

Nurix Therapeutics, Inc.

Quarters held
4
Latest value
$28.3M
Q3 2026
Peak value
$37.4M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$37.4M
Q1 2026$18.5M
Q2 2026$29M
Q3 2026$28.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$28.3M1.19M——
Q2 2026$29M1.19M——
Q1 2026$18.5M1.19M——
Q4 2025$37.4M1.97M——

Other funds holding NRIX

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M